BNT162b2 vaccine induces moderate SARS-CoV-2 immunity in children 5 to 11
In a recent study published in the New England Journal of Medicineresearchers evaluated the effectiveness of the BNT162b2 vaccine against the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant…